HomeEKTA-B • STO
add
Elekta AB (publ)
Previous close
kr 48.16
Day range
kr 48.42 - kr 49.48
Year range
kr 44.50 - kr 76.30
Market cap
18.04B SEK
Avg Volume
1.05M
P/E ratio
78.94
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Apr 2025info | Y/Y change |
---|---|---|
Revenue | 5.16B | 2.67% |
Operating expense | 1.24B | 7.25% |
Net income | -386.00M | -193.01% |
Net profit margin | -7.49 | -190.68% |
Earnings per share | 1.11 | -3.48% |
EBITDA | 983.00M | 17.16% |
Effective tax rate | -24.59% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Apr 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.96B | 6.33% |
Total assets | 28.98B | -7.75% |
Total liabilities | 20.13B | -2.45% |
Total equity | 8.85B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.09 | — |
Return on assets | 6.73% | — |
Return on capital | 11.53% | — |
Cash Flow
Net change in cash
(SEK) | Apr 2025info | Y/Y change |
---|---|---|
Net income | -386.00M | -193.01% |
Cash from operations | 1.57B | 19.06% |
Cash from investing | -320.00M | 27.93% |
Cash from financing | -1.64B | -214.53% |
Net change in cash | -628.00M | -247.07% |
Free cash flow | 795.25M | -16.10% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,487